Synthetic vasopressin analog used for diabetes insipidus, nocturnal enuresis, and mild hemophilia A / von Willebrand disease.
1-deamino-8-D-arginine vasopressin. Selective V2 receptor agonist (renal water retention) with minimal V1 pressor effect; also releases factor VIII and vWF from endothelium.
Evidence summary in progress. See the citations section below for the underlying research papers.
Terms pulled directly from the referenced source. We don't fabricate frequencies — when a label doesn't publish a percentage, we don't either.
No documented drug interactions on file.
FDA approved for central diabetes insipidus, nocturnal enuresis, nocturia, and bleeding disorders (DDAVP, Nocdurna, Stimate)
Not available via 503A/503B compounding pharmacies.
Regulatory data last verified 4/19/2026
Showing 12 of 25 indexed studies. View all on ClinicalTrials.gov →
Showing 20 of 30 papers. View all on PubMed →